MEDICAL RESEARCH TAKING PLACE FOR WOMEN DEALING WITH DISTRESSING LACK OF SEXUAL DESIRE

 

Clinical research study underway in Norfolk to address decreased sexual desire in both pre- and post-menopausal women

 

(NORFOLK, VIRGINIA) – Have you experienced a decrease in sexual desire that bothers you or affects your relationship? You are not alone. Nearly one in 10 women report having low desire with sexually-related personal distress, a problem that can be Hypoactive Sexual Desire Disorder (HSDD) or secondary to other medical conditions, medication use, substance abuse or psychosocial factors.

 

HSDD is characterized by a persistent lack (or absence) of sexual fantasies or desire for any form of sexual activity marked by distress or interpersonal difficulty and not better accounted for by another disorder (except another sexual dysfunction), the direct physiologic effects of a substance (including medications) or a general medical condition.  Dr. Barry Lubin in Norfolk is at the forefront of a nationwide clinical study to test the effectiveness and safety of an investigational oral medication for women with HSDD.

 

"We know there is an unmet medical need to address women suffering with low sexual desire with associated distress," said Sheryl Kingsberg, Ph.D., a study investigator conducting the trial, Professor of the Department of Reproductive Biology at Case Western Reserve University School of Medicine and President of the International Society for the Study of Women’s Sexual Health (ISSWSH). “Currently there is no approved treatment for low sexual desire in women. This research study is a positive step toward more openly discussing women’s low libido.”

 

HSDD is a medical condition that is often described by women as suffering from a lack of, or decrease in, sexual desire. HSDD has been recognized as a medical condition for more than 30 years and affects women of all ages and at any stage of life.

 

Study sites in the area are currently looking for women age 18 and older who are experiencing a distressing decrease in their sexual desire to participate in the study of this investigational medication for HSDD. Qualified participants will receive the investigational study medication, which is in pill form, study-related medical exams and lab tests at no charge. Financial compensation for participation may also be available.

 

This investigational medical research study is taking place in Norfolk and other cities across the United States. For more information, including specific qualifying criteria, visit www.DecreasedSexualDesire.com or call 1-877-705-8787.